Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_08-cv-05590/USCOURTS-cand-5_08-cv-05590-23/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Case Number C 08-5590 JF (HRL)

ORDER GRANTING MEDIMMUNE'S MOTION FOR LEAVE TO ASSERT COUNTERCLAIMS

(JFLC1)

**E-Filed 6/7/2010**

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

MEDIMMUNE, LLC,

 Plaintiff,

 v.

PDL BIOPHARMA, INC.,

 Defendant.

Case Number C 08-5590 JF (HRL)

ORDER GRANTING

MEDIMMUNE’S MOTION FOR

LEAVE TO ASSERT

COUNTERCLAIMS

re: documents no. 477, 515

Plaintiff MedImmune, LLC (“MedImmune”) moves for leave to assert “counterclaims-inreply” in its reply to Defendant PDL BilPharma, Inc.’s (“PDL”) First Amended Answer,

Defenses, and Counterclaims. On May 21, 2010, PDL filed a statement of non-opposition to the

motion. Pursuant to Civil Local Rule 7-1(b), the Court has determined that the motion is

appropriate for determination without oral argument. Having reviewed the moving papers, the

Court concludes that the motion is well-taken. Accordingly, the motion is GRANTED. The

hearing date on the motion is hereby vacated. 

IT IS SO ORDERED.

DATED: 6/7/10

__________________________________

JEREMY FOGEL

United States District Judge

Case 5:08-cv-05590-JF Document 538 Filed 06/07/10 Page 1 of 1